MIP Technologies And Supelco Launch A New Selective SPE Product For The Extraction Of Amphetamine And Related Drugs
A simple, fast, selective and highly sensitive SPE product has been developed for trace level determinations in forensic, toxicological and pharmaceutical testing. The SPE phase has been evaluated for amphetamine, methamphetamine, phentermine, MDA, MDMA and MDEA. Recoveries are high and the extracts show minimized ion suppression in urine and oral fluids.
"SupelMIP SPE-Amphetamines expand the SupelMIP product portfolio into the drugs of abuse area. The detection levels are in the low ppt (part per trillion) range, which is far lower than competing extraction phases on the market and makes the SupelMIP product ideal for difficult forensic applications where drug concentrations may be low and sensitivity is critical," said Dr Christine Widstrand, VP Sales and Marketing at MIP Technologies.
The product is currently being tested at the hospital laboratory in Angelholm, Sweden. This laboratory is accredited for drug screening in workplaces and schools as well as being a confirmative testing reference site for the southern part of Sweden. "We are very excited to test this new class-selective SPE phase," said Carl Magnusson, Head of the department of Clinical Chemistry, Angelholm Hospital.
"This new SPE phase provides added value to the customers by being efficiently class-selective and allowing for lower limits of quantitation for the confirmation of this common drug of abuse," said An Trinh, Product Manager, Supelco.
The SPE sorbents based on molecularly imprinted polymers have been developed by MIP Technologies.
SupelMIP(TM) is a trademark of Supelco, the worldwide product distributor.
About MIP Technologies
MIP Technologies AB is a world-leading company in the development of molecularly imprinted polymers (MIPs). The Company is a pioneer in the commercial applications of MIPs, holds important patents and maintains cutting-edge research activities in this area. The Company's mission is to provide innovative products based on molecularly imprinted polymers that serve industry's needs in analytical, preparative and process scale 'selective separations'. The Company has environmental permission to produce MIP phases at the 500 kg level and is well placed to develop large scale separation solutions for its customers. Currently, the Company develops analytical separation products (e.g. SPE) and has multiple custom process scale projects in place with several blue chip companies. MIP Technologies has its headquarters in Lund, Sweden. For more information about MIP Technologies AB visit http://www.miptechnologies.com.
About Sigma-Aldrich
Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical, analytical, and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 36 countries and has 7,800 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://sigma-aldrich.com.
Cautionary Statement
This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Companies' expectations, goals, beliefs, intentions and the like, which involve assumptions regarding the Companies' operations and conditions in the markets the Companies serve. The Companies do not undertake any obligation to update these forward-looking statements.
Sigma-Aldrich
MIP tehnologii ºi Supelco lansa un nou produs selective SPE pentru extracþia de amfetamine ºi Droguri - MIP Technologies And Supelco Launch A New Selective SPE Product For The Extraction Of Amphetamine And Related Drugs - articole medicale engleza - startsanatate